Objective: An association between streptococcal infections, ABGA positivity, and no comorbidity ADHD (nc-ADHD) has been little investigated. The aim of this study was to evaluate the streptococcal infection frequency, defined entitled serum antistreptolysin O (ASO), and frequency of serum ABGA positivity in a sample of patients with nc-ADHD. Method: In all 40 participants were investigated the ASO titer and ABGA. Results: The results showed that ABGA positivity was statistically significantly higher in patients affected by ADHD than in patients of a control group, and pathological values of ASO were statistically more frequent in the ADHD group than the control group. Conclusion: These data suggest that streptococcal infections and autoimmune reactions against the basal ganglia are more frequent in ADHD patients than patients in a control group.
AlexanderG. E.DelongM. R.StrickP. L. (1986). Parallel organization of functionally segregated circuit linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4.
ChurchA. J.CardosoF.DaleR. C.LeesA. J.ThompsonE. J.GiovannoniG. E. J. (2002). Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology, 59, 227-231.
5.
ChurchA. J.DaleR. C.CardosoF.CandlerP. M.ChapmanM. D.AllenM. L.. . . GiovannoniG. (2003). CSF and serum immune parameters in Sydenham’s chorea: Evidence of an autoimmune syndrome?Journal of Neuroimmunology, 136, 149-153.
6.
ChurchA. J.DaleR. C.GiovannoniG. (2004). Anti-basal ganglia antibodies: A possible diagnostic utility in idiopathic movement disorders?Archives of Disease in Childhood, 89, 611-614.
7.
Commission on Classification and Terminology of the International League Against Epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia30, 389-399.
8.
DaleR. C. (2005). Post-streptococcal autoimmune disorders of the central nervous system. Developmental Medicine and Child Neurology, 47,785-791.
9.
DaleR. C.CandlerP. M.ChurchA. J.WaitR.PopockJ. M.GiovannoniG. (2006). Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Journal of Neuroimmunology, 172, 187-197.
10.
DaleR. C.ChurchA. J.SurteesR. A.LeesA. J.AdcockJ. E.MardingB.. . . GiovannoniG. (2004). Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain, 127, 21-33.
11.
HaberS. N. (2003). The primate basal ganglia: Parallel and integrative networks. Journal of Chemical Neuroanatomy, 26, 317-330.
12.
HallettJ.Harling-BergC. J.KnopfP. M.StopaE. G.KiesslingL. S. (2000). Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. Journal of Neuroimmunology, 111, 195-202.
13.
Headache Classification Subcommittee of the International Headache Society (2004). The International Classification of Headache Disorders, 2nd edn. Cephalalgia, 24, 1-160.
14.
HoffmanK. L.HoringM.YaddonapudiI. C.JabadoO.LipkinW. I. (2004). A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. Journal of Neuroscience, 24, 1780-1791.
15.
JensenP. S. (2000). Attention-deficit/hyperactivity disorder: Concepts on etiology, pathophysiology and neurobiology. Child and Adolescent Psychiatric Clinics of North America, 9, 557-572.
16.
KaplanE. L.RothermelC. D.JohnsonD. R. (1998). Antistreptolysin O and anti deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the U.S.A. Pediatrics, 101, 86-88.
17.
KiesslingL. S.MarcotteA. C.CulpepperL. (1993). Antineural antibodies in movement disorder. Pediatrics, 92, 39-43.
18.
KirvanC. A.SwedoS. E.HeuserJ. S.CunnighamM. W. (2003). Mimicry and autoantibody-mediated neuronal cell signalling in Sydenham’s chorea. Nature Medicine, 9, 914-920.
19.
KurlanR. (2001). Could Tourette syndrome be a neurologic manifestation of rheumatic fever?Advances in Neurology, 85, 307-310.
20.
KurlanR.JohnsonD.KaplanE. L., & the Tourette Syndrome Study Group. (2008). Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study. Pediatrics, 121, 1188-1197.
21.
LeslieD. L.KozmaL.MartinA.LanderosA.KatsovichL.KingR. A.LeckmanJ. F. (2008). Neuropsychiatric disorders associated with Streptococcal infection: A case-control study among privately insured children. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 1166-1172. doi:10.1097/CHI10.1097/CHI
22.
LoiselleC. R.WendlandtJ. T.RohdeC. A.SingerH. S. (2003). Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatric Neurology, 28, 119-125.
23.
LouH. C.AndersenJ.SteinbergB.Mc LauglinT.FribergL. (1998). The striatum in a putative cerebral network activated by verbal awareness in normal and ADHD children. European Journal of Neurology, 5, 67-74.
24.
MargariL.VenturaP.PortogheseC.PresicciA.ButtiglioneM.Di CuonzoF. (2006). Brain magnetic resonance spectroscopy in Sydenham’s chorea and ADHD. Pediatric Neurology, 34, 467-473.
25.
MartinoD.ChurchA. J.DefazioG. (2005). Soluble adhesion molecules in Gilles de la Tourette’s syndrome. Journal of the Neurological Sciences, 234, 79-85.
26.
MartinoD.DefazioG.ChurchA. J.RussellC.DaleR. C.GiovannoniG.. . . OrthM. (2007). Antineuronal antibody status and phenotype analysis in Tourette’s syndrome. Movement Disorders, 22, 1424-1429.
27.
MercadanteM. T.HounieA. G.DinizJ. B.MiguelE. C.LombrosoP. J. (2001). The basal ganglia and immune-based neuropsychiatric disorders. Psychiatric Annals, 31, 534-540.
28.
MinkJ. W. (2001). Basal ganglia dysfunction in Tourette’s syndrome: A new hypothesis. Pediatric Neurology, 25, 190-198.
29.
MorshedS. A.ParveenS.LeckmanJ. F.MercadanteM. T.Bittencourt KissM. H.MiguelE. C.. . . LombrosoP. J. (2001). Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette syndrome, Sydenham’s chorea and autoimmune disorders. Biological Psychiatry, 50, 566-577.
30.
MullerN.RiedelM.StraubeA.GuntherW.WilskeB. (2000). Increased anti-streptococcal antibodies in patients with Tourette’s syndrome. Psychiatry Research, 94, 43-49.
31.
PetersonB. S.LeekmanJ. F.TuckerD.ScahillL.StaibL.ZhangH.. . . LombrosoP. (2000). Preliminary finding of streptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Archives of General Psychiatry, 57, 364-372.
32.
PolanczykG.de LimaM. S.HortaB.BiedermanJ.RohdeL. A. (2007). The Worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.
33.
Sanchez-CarpinteroR.AlbesaS. A.CrespoN.VillosladaP.NarbonaJ. (2009). A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. Journal of Neurology, 256, 1103-1108.
34.
SheppardD. M.BradshawJ. L.PurcellR.PantelisC. (1999). Tourette’s and comorbid syndromes: Obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?Clinical Psychology Review, 19, 531-552.
35.
SingerH. S.GiulianoJ. D.HansenB. H.LaurinoJ. P.BensonM.KiesslingL. S. (1998). Antibodies against human putamen in children with Tourette syndrome. Neurology, 50, 1618-1624.
36.
SwansonJ. M.SergeantJ. A.TaylorE.Sonuga-BarkeE. J. S.JensenP. S.CantwellD. P. (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet, 351, 429-433.
37.
SwedoS. E. (1994). Sydenham’s chorea: A model for childhood autoimmune neuropsychiatric disorder. Journal of the American Medical Association, 272, 1788-1791.
38.
SwedoS. E.LeonardH. L.GarveyM.MittlemanB.AllenA. J.PerlmutterS.. . . DubbertB. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264-271.
39.
TannockR. (1998). Attention deficit hyperactivity disorder: Advance in cognitive, neurobiological, and genetic research. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 39, 65-99.
40.
TeixeiraA. L.Jr.CardosoF.SouzaA. L.TeixeiraM. M. (2004). Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham’s chorea patients. Journal of Neuroimmunology, 150, 157-162.
